|
Volumn 140, Issue 9, 2004, Pages 1151-1152
|
Twice-weekly topical corticosteroid therapy may reduce atopic dermatitis relapses
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CORTICOSTEROID;
EMOLLIENT AGENT;
FLUTICASONE PROPIONATE;
ADOLESCENT;
ADULT;
ATOPIC DERMATITIS;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORTICOSTEROID THERAPY;
CREAM;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
HUMAN;
MAINTENANCE THERAPY;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
NOTE;
OINTMENT;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RECURRENCE RISK;
RELAPSE;
SKIN ATROPHY;
TELANGIECTASIA;
TOPICAL DRUG ADMINISTRATION;
ADMINISTRATION, TOPICAL;
ADOLESCENT;
ADRENAL CORTEX HORMONES;
ADULT;
AGED;
ANDROSTADIENES;
CHILD;
DERMATITIS, ATOPIC;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
EMOLLIENTS;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
MIDDLE AGED;
RECURRENCE;
RISK ASSESSMENT;
TREATMENT OUTCOME;
|
EID: 4544356841
PISSN: 0003987X
EISSN: None
Source Type: Journal
DOI: 10.1001/archderm.140.9.1151 Document Type: Note |
Times cited : (12)
|
References (7)
|